Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tenaya Therapeutics Inc
TNYACurrent price
2.02 USD
-0.04 USD (-1.94%)
Last closed
2.09 USD
Company
www.tenayatherapeutics.com
ISIN
US87990A1060
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
218 648 576 USD
Yield for 12 month
+10.99 %
1Y
3Y
5Y
10Y
15Y
TNYA
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Address: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.43 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-8 687 000 USD
Last Year
-8 713 000 USD
Current Quarter
–
Last Quarter
-2 123 000 USD
Key Figures TNYA
1 year
3 years
5 years
10 years
EBITDA
-114 182 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.94 %
PEG Ratio
–
Return On Equity TTM
-84.49 %
Wall Street Target Price
19.43 USD
Revenue TTM
–
Book Value
1.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.44 USD
Diluted Eps TTM
-1.44 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TNYA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TNYA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TNYA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.6742
Price Book MRQ
1.9337
Financials TNYA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TNYA
For 52 weeks
1.61 USD
7.01 USD
50 Day MA
2.05 USD
Shares Short Prior Month
5 076 862
200 Day MA
3.65 USD
Short Ratio
9.77
Shares Short
4 876 224
Short Percent
8.87 %
BeatStart